FormWeb • estradiol-norethindrone

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

estradiol-norethindrone

estradiol-norethindrone

Formulary Estrogen Patch Formulary

Drug Name	Form	Strength
Combipatch	FILM, EXTENDED RELEASE, TRANSDERMAL	0.05 mg-0.14 mg/24 hours
Combipatch	FILM, EXTENDED RELEASE, TRANSDERMAL	0.05 mg-0.25 mg/24 hours
Activella, Mimvey	TABLET, ORAL	0.5 mg-0.1 mg, 1 mg-0.5 mg

VIEW MORE Estrogens

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

estradiol-norethindrone (Combipatch)

0.05 mg-0.25 mg/24 hours extended release film transdermal twice weekly

estradiol-norethindrone (Combipatch)

0.05 mg-0.14 mg/24 hours extended release film transdermal twice weekly

Activella is restricted to use other than for contraception.

Reviewed: 27 March 2018

Last updated: Feb. 3, 2025

Restricted
Restricted Activella --> Restricted to use other than contraception.
Black Box Warning: Cardiovascular and other risks; probable dementia
HAZ-MED: Table 2H (estradiol)
HAZ-MED: Table 2H (norethindrone)
Formulary, Not Routinely Stocked: Activella 0.5 mg-0.1 mg

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.